Literature DB >> 10576039

Tacrolimus-based immunosuppression in pediatric renal transplantation.

M L Jordan1, R Shapiro, V Scantlebury, C Vivas, D Ellis, S Lombardozzi-Lane, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10576039      PMCID： PMC2976502          DOI： 10.1016/s0041-1345(99)00790-3

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  11 in total

1.  Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group.

Authors:  A D Mayer; J Dmitrewski; J P Squifflet; T Besse; B Grabensee; B Klein; F W Eigler; U Heemann; R Pichlmayr; M Behrend; Y Vanrenterghem; J Donck; J van Hooff; M Christiaans; J M Morales; A Andres; R W Johnson; C Short; B Buchholz; N Rehmert; W Land; S Schleibner; J L Forsythe; D Talbot; E Pohanka
Journal:  Transplantation       Date:  1997-08-15       Impact factor: 4.939

2.  Preliminary experience with FK 506 in pediatric renal transplant recipients: a single-center report.

Authors:  P E Birk; M E Cook; W J Schmidt; B M Chavers
Journal:  Transplant Proc       Date:  1996-04       Impact factor: 1.066

3.  Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients.

Authors:  M McKee; D Segev; B Wise; B Case; A Neu; B Fivush; P Colombani
Journal:  J Pediatr Surg       Date:  1997-05       Impact factor: 2.545

4.  Kidney transplantation under FK 506.

Authors:  T E Starzl; J Fung; M Jordan; R Shapiro; A Tzakis; J McCauley; J Johnston; Y Iwaki; A Jain; M Alessiani
Journal:  JAMA       Date:  1990-07-04       Impact factor: 56.272

5.  Pediatric renal transplantation under tacrolimus-based immunosuppression.

Authors:  R Shapiro; V P Scantlebury; M L Jordan; C Vivas; D Ellis; S Lombardozzi-Lane; N Gilboa; H A Gritsch; W Irish; J McCauley; J J Fung; T R Hakala; R L Simmons; T E Starzl
Journal:  Transplantation       Date:  1999-01-27       Impact factor: 4.939

6.  A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.

Authors:  J D Pirsch; J Miller; M H Deierhoi; F Vincenti; R S Filo
Journal:  Transplantation       Date:  1997-04-15       Impact factor: 4.939

7.  Pediatric renal transplantation under FK-506 immunosuppression.

Authors:  F X Schneck; M L Jordan; C W Jensen; R Shapiro; A Tzakis; V P Scantlebury; D Ellis; N Gilboa; R L Simmons; T R Hakala
Journal:  J Urol       Date:  1992-06       Impact factor: 7.450

8.  Comparison of FK-506 and cyclosporine regimens in pediatric renal transplantation.

Authors:  D Ellis; R Shapiro; M L Jordan; V P Scantlebury; N Gilboa; L Hopp; N Weichler; A G Tzakis; R L Simmons
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

9.  A prospective randomized trial of FK506-based immunosuppression after renal transplantation.

Authors:  R Shapiro; M L Jordan; V P Scantlebury; C Vivas; J J Fung; J McCauley; P Randhawa; A J Demetris; W Irish; S Mitchell
Journal:  Transplantation       Date:  1995-02-27       Impact factor: 4.939

10.  FK506 in pediatric kidney transplantation--primary and rescue experience.

Authors:  R Shapiro; V P Scantlebury; M L Jordan; C Vivas; A G Tzakis; D Ellis; N Gilboa; L Hopp; J McCauley; W Irish
Journal:  Pediatr Nephrol       Date:  1995       Impact factor: 3.714
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.